Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Status: Opinion
Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Izamby, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Junod, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Dazluma, troriluzole, Status: Application withdrawn
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2025
Summary of opinion: Zoonotic Influenza Vaccine Seqirus, 25/04/2025 Positive
Summary of opinion: Adcetris, 25/04/2025 Positive